Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Related Articles by Review for PubMed (Select 18315449)

1.

A prospective 12-week study of quetiapine in adolescents with schizophrenia spectrum disorders.

Schimmelmann BG, Mehler-Wex C, Lambert M, Schulze-zur-Wiesch C, Koch E, Flechtner HH, Gierow B, Maier J, Meyer E, Schulte-Markwort M.

J Child Adolesc Psychopharmacol. 2007 Dec;17(6):768-78. doi: 10.1089/cap.2007.0048.

PMID:
18315449
2.

Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?

Tollefson GD, Andersen SW.

J Clin Psychiatry. 1999;60 Suppl 5:23-9; discussion 30. Review.

PMID:
10192404
3.

Quetiapine extended release: in schizophrenia.

Baldwin CM, Scott LJ.

CNS Drugs. 2009;23(3):261-9. doi: 10.2165/00023210-200923030-00007. Review.

PMID:
19320534
4.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
5.

Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review.

Saavedra-Velez C, Yusim A, Anbarasan D, Lindenmayer JP.

J Clin Psychiatry. 2009 Jan;70(1):104-12. Epub 2008 Nov 18. Review.

PMID:
19026265
6.

The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis.

Emsley R, Rabinowitz J, Torreman M; RIS-INT-35 Early Psychosis Global Working Group.

Schizophr Res. 2003 May 1;61(1):47-57. Review.

PMID:
12648735
7.

The CATIE schizophrenia trial: results, impact, controversy.

Manschreck TC, Boshes RA.

Harv Rev Psychiatry. 2007 Sep-Oct;15(5):245-58. Review.

PMID:
17924259
8.

Quetiapine: efficacy, tolerability and safety in schizophrenia.

Miodownik C, Lerner V.

Expert Rev Neurother. 2006 Jul;6(7):983-92. Review.

PMID:
16831113
9.

Safety of low doses of quetiapine when used for insomnia.

Coe HV, Hong IS.

Ann Pharmacother. 2012 May;46(5):718-22. doi: 10.1345/aph.1Q697. Epub 2012 Apr 17. Review.

PMID:
22510671
10.

Quetiapine: dose-response relationship in schizophrenia.

Sparshatt A, Jones S, Taylor D.

CNS Drugs. 2008;22(1):49-68; discussion 69-72. Review.

PMID:
18072814
11.

Antipsychotics in early onset Schizophrenia: Systematic review and meta-analysis.

Armenteros JL, Davies M.

Eur Child Adolesc Psychiatry. 2006 Mar;15(3):141-8. Epub 2006 Feb 9. Review.

PMID:
16470340
12.

Symptom rating scales and outcome in schizophrenia.

Mortimer AM.

Br J Psychiatry Suppl. 2007 Aug;50:s7-14. Review.

PMID:
18019038
13.

Effects of quetiapine on sleep in nonpsychiatric and psychiatric conditions.

Wine JN, Sanda C, Caballero J.

Ann Pharmacother. 2009 Apr;43(4):707-13. doi: 10.1345/aph.1L320. Epub 2009 Mar 18. Review.

PMID:
19299326
14.

Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents.

Correll CU, Carlson HE.

J Am Acad Child Adolesc Psychiatry. 2006 Jul;45(7):771-91. Review.

PMID:
16832314
15.

Atypical antipsychotics in severe anorexia nervosa in children and adolescents--review and case reports.

Mehler-Wex C, Romanos M, Kirchheiner J, Schulze UM.

Eur Eat Disord Rev. 2008 Mar;16(2):100-8. Review.

PMID:
18000964
16.

Clozapine use in children and adolescents.

Gogtay N, Rapoport J.

Expert Opin Pharmacother. 2008 Feb;9(3):459-65. doi: 10.1517/14656566.9.3.459 . Review.

PMID:
18220495
17.

The diagnosis and treatment of children and adolescents with schizophrenia. "My mind is playing tricks on me".

Kumra S.

Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):183-99, x. Review.

PMID:
10674196
18.

Is the PANSS used correctly? a systematic review.

Obermeier M, Schennach-Wolff R, Meyer S, Möller HJ, Riedel M, Krause D, Seemüller F.

BMC Psychiatry. 2011 Jul 18;11:113. doi: 10.1186/1471-244X-11-113. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk